(Q28377643)

2

0 references

E Dincer

3

0 references

R Wang

4

0 references

T Komodromos

5

0 references

O Ibarra-Sunga

6

0 references

G Filippatos

7

0 references

B D Uhal

American Journal of Physiology - Lung Cellular and Molecular Physiology

8

0 references

language of work or name

English

0 references

publication date

May 2000

0 references

published in

0 references

volume

278

0 references

issue

5

0 references

page(s)

L1039-44

0 references

cites work

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Natural killer cell activity in a rat model of amiodarone-induced interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Enzymatic programming of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Amiodarone-induced phospholipidosis in rat alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Cell cycle kinetics in the alveolar epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Responses of the lung to toxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039

Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2000.278.5.L1039